In this episode of the Defence Connect Spotlight podcast, Tony Howell, global chief architect, defence and intelligence at archTIS, joins host Liam Garman to assess how Australian businesses can utilise the AUKUS agreement to expand into British and American markets.
- The podcast begins with a discussion as to whether the introduction of critical military technologies under AUKUS, including nuclear propulsion, will make Australian companies the targets of sophisticated overseas cyber threat actors, before unpacking how local companies can protect themselves.
- Howell then provides insight for Australian defence companies looking to expand into the US and the UK markets, and what regulatory and legislative data requirements they are likely to face.
- The pair then wrap up the podcast analysing the future of ITAR, and how archTIS can support companies navigating ITAR requirements in their growth cycle.
Enjoy the podcast,
The Defence Connect team
Listen to previous episodes of the Defence Connect podcast:
Episode 493: PODCAST: How geopolitics must influence Australia’s force posture, with Mike Pezzullo
Episode 492: CONTESTED GROUND: Where does the misinformation bill leave free speech?
Episode 491: SPOTLIGHT: Engaging the national innovation ecosystem, with DSTG’s Dr Robert Hunjet
Episode 490: SPOTLIGHT: Protecting your data as Australia moves to an AI future, with Hrvoje Hančević-Grabić from IT Strategy Hub
Episode 489: SPOTLIGHT: Scaling advanced manufacturing, with Anduril’s Brian Schimpf and David Goodrich
Episode 488: SPOTLIGHT: How quantum will revolutionise PNT and RF sensing, with DSTG’s Andrew Seedhouse and QuantX’s Andre Luiten
Episode 487: DEFENCE PROPERTY PODCAST: Investing in property from post to post
Episode 486: SPOTLIGHT: Quantum – revolutionising Defence, health and energy – with Dr Cathy Foley, Australia’s chief scientist
Episode 485: CONTESTED GROUND: Unpacking resource and food security, with Senator Matt Canavan
Episode 484: SPOTLIGHT: Commercialising academic and industry research, with Defence Trailblazer’s Dr Sanjay Mazumdar